Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%-Reference-Cited by-同舟云学术

Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%

Published:2010-11-24 Issue:2 Volume:152 Page:175-181
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Mohamedbhai Sajir G.,Sibson Keith,Marafioti Teresa,Kayani Irfan,Lowry Lisa,Goldstone Anthony H.,Linch David C.,Ardeshna Kirit M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2010.08447.x/fullpdf

Reference16 articles.

1. Revised response criteria for malignant lymphoma;Cheson;Journal of Clinical Oncology,2007

2. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;New England Journal of Medicine,2002

3. Efficacy and toxicity of dose-adjusted EPOCH-rituximab in adults with newly diagnosed Burkitt lymphoma;Dunleavy;Journal of Clinical Oncology (ASCO Annual Meeting Proceedings Part I),2007

4. Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival;Johnson;Blood,2009

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine in Burkitt and Burkitt-Like Lymphomas;Molecular Pathology Library;2023

2. Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis;Frontiers in Oncology;2022-12-23

3. Successful conservative management of pelvic lytic lesion in a child with Burkitt's Lymphoma: A rare case report;Journal of Orthopaedic Reports;2022-12

4. Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index;Neoplasma;2022

5. Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma;Current Treatment Options in Oncology;2021-06-07